Software engineers can heave a sigh of relief. Your job may get changed/altered a bit, but it is not going anywhere according to the CEO of India's second-biggest IT company Infosys. In an interview ...

Stock market crash: Experts suggest that a robust recovery in the Nasdaq is essential to mitigate the negative impact on Indian markets.(Photo: Courtesy AI) Birlasoft, Firstsource Solutions Ltd (FSL), ...

MUMBAI- Infosys CEO and Managing Director Salil Parekh on January 14 denied claims that any Infosys employee was detained or deported by US authorities, responding to a viral post on social media that ...

IT shares declined for fourth straight day on February 23 with the latest negative trigger being Jefferies downgrading six IT shares amid concerns over artificial intelligence. In late morning trade, ...

The stock of Bengaluru-based IT services firm declined over 2 percent to Rs 1,325 during the early trade hours on Monday. While the stock opened higher at Rs 1,354 than its previous close of Rs 1,352, ...

IT stocks are once again in focus, but for all the red reasons. The sector is once again suffering sharp losses after Anthropic highlighted the potential of its Claude Code tool to modernise legacy ...

The Nifty IT Index fell nearly 2% in trade even as the broader market stayed firm and all ten constituents of the IT index were trading in the red. Stocks that saw big dent included the likes of ...

IT stocks have witnessed heightened volatility in recent trading sessions, as investors reassess the sector’s outlook amid mounting concerns over the disruptive impact of artificial intelligence, ...

Citrini Research, in a note titled “The 2028 Global Intelligence Crisis,” outlined a scenario in which contract cancellations at Tata Consultancy Services Ltd, Infosys Ltd and Wipro would accelerate ...

JM Financial has maintained a ‘Buy’ rating on Infosys with a 12-month target price of Rs 1,660. With the current market price at Rs 1,391, this implies an upside of about 19.3%. The brokerage said, ...

Eligible individuals with commercial insurance may pay as little as $25 for a one-month or three-month supply of Mounjaro through the manufacturer’s savings card program. Doctors may provide free ...